ISSN: 1230-2813
Advances in Psychiatry and Neurology/Postępy Psychiatrii i Neurologii
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
3/2018
vol. 27
 
Share:
Share:
more
 
 
abstract:
Review article

Heart rate variability as a method of autonomic nervous system assessment in selected psychiatric disorders

Olga Sikorska, Katarzyna Szaulińska, Henryk Dudek, Adam Wichniak

Adv Psychiatry Neurol 2018; 27 (3): 232-246
Online publish date: 2018/09/30
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
Analysis of heart rate variability (HRV) based on ECG is a non-invasive method which assesses the activity of both the sympathetic and the parasympathetic part of autonomic nervous system. HRV measurement describes time differences between consecutive heartbeats – intervals between the R waves of the QRS complex. The aim of the article is to present results of research on HRV in selected mental disorders.

Views
People with mental disorders have reduced HRV, especially components dependent on parasympathetic activity, and more often than healthy subjects develop cardiovascular diseases. Moreover, drugs psychiatric drugs can also have negative influence on HRV. Reduction of HRV, dependent on sympathetic predominance, has been described in numerous mental disorders – schizophrenia, affective and anxiety disorders, insomnia. Among the antipsychotics, the least favorable for heart is the effect of clozapine, treatment with amisulpride and risperidone seems safe. Antidepressants also have a different cardiological safety profile. The least beneficial is the action of tricyclic antidepressants. Venlafaxine and mirtazapine also lower HRV, while SSRIs, including paroxetine which has the largest in this group cholinolytic action, seem to be safe. In the case of HRV-reducing drugs it is advisable to use the lowest effective dose, as the HRV parameters are reduced with increasing the dose of the drug.

Conclusions
HRV analysis is reliable and technically easy to perform. The results of presented studies indicate that HRV assessment may be widely used in psychiatry as a biological marker of an autonomic excitation and to evaluate cardiological safety of drugs.

keywords:

psychiatric disorders, autonomic nervous system, heart rate variability, HRV

references:
Taralov ZZ, Terziyski KV, Kostianev SS. Heart Rate Variability as a Method for Assessment of the Autonomic Nervous System and the Adaptations to Different Physiological and Pathological Conditions. Folia Med (Plovdiv) 2015; 57: 173-180. DOI: 10.1515/folmed-2015-0036.
Florea VG, Cohn JN. The autonomic nervous system and heart failure. Circ Res 2014; 114: 1815-1826. DOI: 10.1161/CIRCRESAHA.114.302589.
Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-381.
Niskanen JP, Tarvainen MP, Ranta-Aho PO, Karjalainen PA. Software for advanced HRV analysis. Comput Methods Programs Biomed 2004; 76: 73-81.
Dong JG. The role of heart rate variability in sports physiology. Exp Ther Med 2016; 11: 1531-1536. Epub 2016 Feb 23.
Birkhofer A, Geissendoerfer J, Alger P, Mueller A, Rentrop M, Strubel T, Leucht S, Förstl H, Bär KJ, Schmidt G. The deceleration capacity – a new measure of heart rate variability evaluated in patients with schizophrenia and antipsychotic treatment. Eur Psychiatry 2013; 28: 81-86. DOI: 10.1016/j.eurpsy.2011.06.010. Epub 2011 Sep 14.
Chang JS, Yoo CS, Yi SH, Hong KH, Oh HS, Hwang JY, Kim SG, Ahn YM, Kim YS. Differential pattern of heart rate variability in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 991-995. DOI: 10.1016/j.pnpbp.2009.05.004. Epub 2009 May 7.
Hempel RJ, Tulen JH, van Beveren NJ, Röder CH, Hengeveld MW. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia. J Psychopharmacol 2009; 23: 697-707. DOI: 10.1177/0269881108091254. Epub 2008 Jun 18.
Agelink MW, Majewski T, Wurthmann C, Lukas K, Ullrich H, Linka T, Klieser E. Effects of newer atypical anti-psychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine. J Clin Psychopharmacol 2001; 21: 8-13.
Cohen H, Loewenthal U, Matar M, Kotler M. Association of autonomic dysfunction and clozapine. Heart rate variability and risk for sudden death in patients with schizophrenia on long-term psychotropic medication. Br J Psychiatry 2001; 179: 167-171.
Wang YC, Yang CC, Bai YM, Kuo TB. Heart rate variability in schizophrenic patients switched from typical antipsychotic agents to amisulpride and olanzapine. 3-month follow-up. Neuropsychobiology 2008; 57: 200-205. DOI: 10.1159/000149818. Epub 2008 Aug 5.
Mueck-Weymann M, Rechlin T, Ehrengut F, Rauh R, Acker J, Dittmann RW, Czekalla J, Joraschky P, Musselman D. Effects of olanzapine and clozapine upon pulse rate variability. Depress Anxiety 2002; 16: 93-99.
Chang JS, Yoo CS, Yi SH, Hong KH, Lee YS, Oh HS, Jung DC, Kim YS, Ahn YM. Changes in heart rate dynamics of patients with schizophrenia treated with risperidone. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 924-929. DOI: 10.1016/j.pnpbp.2010.04.017. Epub 2010 Apr 25.
Iwamoto Y, Kawanishi C, Kishida I, Furuno T, Fujibayashi M, Ishii C, Ishii N, Moritani T, Taguri M, Hirayasu Y. Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia. BMC Psychiatry 2012; 12: 199. DOI: 10.1186/1471-244X-12-199.
Kemp AH, Quintana DS, Felmingham KL, Matthews S, Jelinek HF. Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk. PLoS One 2012; 7: e30777. DOI: 10.1371/journal.pone.0030777. Epub 2012 Feb 15.
Yeh TC, Kao LC, Tzeng NS, Kuo TB, Huang SY, Chang CC, Chang HA. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA). Prog Neuropsychopharmacol Biol Psychiatry 2016; 64: 60-67. DOI: 10.1016/j.pnpbp.2015.07.007. Epub 2015 Jul 26.
Licht CM, de Geus EJ, Zitman FG, Hoogendijk WJ, van Dyck R, Penninx BW. Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch Gen Psychiatry 2008; 65: 1358-1367. DOI: 10.1001/archpsyc.65.12.1358.
Kemp AH, Quintana DS, Gray MA, Felmingham KL, Brown K, Gatt JM. Impact of depression and antidepressant treatment on heart rate variability: a review and meta-analysis. Biol Psychiatry 2010; 67: 1067-1074. DOI: 10.1016/j.biopsych.2009.12.012. Epub 2010 Feb 6.
Udupa K, Thirthalli J, Sathyaprabha TN, Kishore KR, Raju TR, Gangadhar BN. Differential actions of anti-depressant treatments on cardiac autonomic alterations in depression: A prospective comparison. Asian J Psychiatr 2011; 4: 100-106. DOI: 10.1016/j.ajp.2011.02.006. Epub 2011 May 8.
Terhardt J, Lederbogen F, Feuerhack A, Hamann-Weber B, Gilles M, Schilling C, Lecei O, Deuschle M. Heart rate variability during antidepressant treatment with venlafaxine and mirtazapine. Clin Neuropharmacol 2013; 36: 198-202. DOI: 10.1097/WNF.0b013e3182a76fbb.
Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis. Front Psychiatry 2014; 5: 80. DOI: 10.3389/fpsyt.2014.00080. eCollection 2014.
Licht CM, de Geus EJ, van Dyck R, Penninx BW. Association between anxiety disorders and heart rate variability in The Netherlands Study of Depression and Anxiety (NESDA). Psychosom Med 2009; 71: 508-518. DOI: 10.1097/PSY.0b013e3181a292a6. Epub2009 May 4.
Chang HA, Chang CC, Tzeng NS, Kuo TB, Lu RB, Huang SY. Decreased cardiac vagal control in drug-naive patients with panic disorder: a case-control study in Taiwan. Asia Pac Psychiatry 2013; 5: 80-89. DOI: 10.1111/appy.12032. Epub 2013 Feb27.
Cohen H, Benjamin J, Geva AB, Matar MA, Kaplan Z, Kotler M. Autonomic dysregulation in panic disorder and in post-traumatic stress disorder: application of power spectrum analysis of heart rate variability at rest and in response to recollection of trauma or panic attacks. Psychiatry Res 2000; 96: 1-13.
Slaap BR, Nielen MM, Boshuisen ML, van Roon AM, den Boer JA. Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers. J Affect Disord 2004; 78: 141-148.
Moon E, Lee SH, Kim DH, Hwang B. Comparative Study of Heart Rate Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress Disorder, or Major Depressive Disorder. Clin Psychopharmacol Neurosci 2013; 11: 137-143. DOI: 10.9758/cpn.2013.11.3.137. Epub 2013 Dec 24.
Thayer JF, Friedman BH, Borkovec TD. Autonomic characteristics of generalized anxiety disorder and worry. Biol Psychiatr 1996; 39: 255-266.
Kim K, Lee S, Kim JH. Diminished autonomic neurocardiac function in patients with generalized anxiety disorder. Neuropsychiatr Dis Treat 2016; 12: 3111-3118. eCollection 2016.
Pittig A, Arch JJ, Lam CW, Craske MG. Heart rate and heart rate variability in panic, social anxiety, obsessive-compulsive, and generalized anxiety disorders at baseline and in response to relaxation and hyperventilation. Int J Psychophysiol 2013; 87: 19-27. DOI: 10.1016/j.ijpsycho.2012.10.012. Epub 2012 Oct 27.
Alvares GA, Quintana DS, Kemp AH, Van Zwieten A, Balleine BW, Hickie IB, Guastella AJ. Reduced heart rate variability in social anxiety disorder: associations with gender and symptom severity. PLoS One 2013; 8: e70468. DOI: 10.1371/journal.pone.0070468. Print 2013.
Cohen H, Kaplan Z, Kotler M, Mittelman I, Osher Y, Bersudsky Y. Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord 2003; 5: 138-143.
Henry BL, Minassian A, Paulus MP, Geyer MA, Perry W. Heart rate variability in bipolar mania and schizophrenia. J Psychiatr Res 2010; 44: 168-176. DOI: 10.1016/j.jpsychires.2009.07.011. Epub 2009 Aug 22.
Chang HA, Chang CC, Kuo TB, Huang SY. Distinguishing bipolar II depression from unipolar major depressive disorder: Differences in heart rate variability. World J Biol Psychiatry 2015; 16: 351-360. DOI: 10.3109/15622975.2015.1017606. Epub 2015 Mar 24.
Tobaldini E, Nobili L, Strada S, Casali KR, Braghiroli A, Montano N. Heart rate variability in normal and pathological sleep. Front Physiol 2013; 4: 294. DOI: 10.3389/fphys.2013.00294. Review.
Yang AC, Tsai SJ, Yang CH, Kuo CH, Chen TJ, Hong CJ. Reduced physiologic complexity is associated with poor sleep in patients with major depression and primary insomnia. J Affect Disord 2011; 131: 179-185. DOI: 10.1016/j.jad.2010.11.030. Epub 2010 Dec 31.
Bonnet MH, Arand DL. Heart rate variability in insomniacs and matched normal sleepers. Psychosom Med 1998; 60: 610-615.
Szaulińska K, Pływaczewski R, Sikorska O, Holka-Pokorska J, Wierzbicka A, Wichniak A, Śliwiński P. Obstructive sleep apnea in severe mental disorders. Psychiatr Pol 2015; 49: 883-895. DOI: 10.12740/PP/32566.
Kufoy E, Palma JA, Lopez J, Alegre M, Urrestarazu E, Artieda J, Iriarte J. Changes in the heart rate variability in patients with obstructive sleep apnea and its response to acute CPAP treatment. PLoS One 2012; 7: e33769. DOI: 10.1371/journal.pone.0033769. Epub 2012 Mar 16.
Palma JA, Iriarte J, Fernandez S, Alegre, Valencia M, Artieda J, Urrestarazu E. Long-term continuous positive airway pressure therapy improves cardiac autonomic tone during sleep in patients with obstructive sleep apnea. Clin Auton Res 2015; 25: 225-232. DOI: 10.1007/s10286-015-0297-7. Epub 2015 May 23.
FEATURED PRODUCTS
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe